Live
IlluminaIllumina upgraded to overweight at JPMorgan on clinical demand outlook - Investing.comEndpoints NewsRare disease biotech Beren adds $300M from new financingsClinical OMICsAI Tool Classifies 102 CNS Tumor Subtypes in MinutesClinical OMICsFast-Acting Malaria Drug Shows Promise in First-in-Human StudyClinical OMICsUltrasensitive HPV DNA Blood Test Could Help Personalize Head and Neck Cancer TreatmentClinical OMICsDigital Portal Strengthens Patient Engagement in Cancer Clinical TrialsClinical OMICsAI Detects Breast Cancer Much Earlier than Radiologists AloneFierceBiotechFrom executive assistant to chief executive: Charles River CEO Birgit Girshick on ‘the next big transition’ in the CRO industryEndpoints NewsParabilis CEO Mathai Mammen on biotech's record IPOIlluminaCalls of the day: Illumina, Netflix and REITs - MSNPromega BlogPromega Builds Opportunity to Appreciate Hidden Wetland
This story is not available in the archive.